Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine

NCT03398668 is registered in ClinicalTrials.gov with Neurolief Ltd. as lead sponsor.

NCT NCT03398668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03398668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
Lead sponsor
Neurolief Ltd.
Phase
Not applicable
Overall status
Completed
Start date
February 22, 2018
Completion date
December 30, 2018
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine